Clinical manifestations and results of reconstructive surgeries in patients with primary and secondary mitral insufficiency

Authors

  • O. F. Luchynets National M. Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv,
  • V. V. Lazoryshynets National M. Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv,
  • O. A. Krykunov National M. Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, Kyiv,

DOI:

https://doi.org/10.14739/2310-1210.2020.6.218401

Keywords:

mitral insufficiency, reconstructive surgery, mitral regurgitation

Abstract

 

Mitral valve regurgitation is the most common disorder of the valvular heart lesions; it occurs in 10 % of the population.

Mitral valve reconstruction has become a priority option for mitral regurgitation correction, due to the documented advantages, comparing with valve replacement, in terms of long-term survival, absence of valve-related side effects, and preservation of left ventricle function. Improvement of mitral valve reconstruction techniques has made almost all lesion variants (more than 95 %) suitable for reconstruction, with a 15-year freedom from reoperations in 90 % of all operated patients.

Aim. To study clinical manifestations and results of reconstructive surgeries on the mitral valve in patients with primary and secondary mitral regurgitation.

Materials and methods. The study is based on the analysis of clinical data of 218 patients with mitral valve insufficiency who were treated in National M. Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine from 01.01.2010 to 01.01.2015. The average age of patients was 52.8 ± 13.0 years (16.0–78.0). The ratio of male to female patients was 151 (69.3 %) and 67 (30.7 %) cases, respectively. Acute occurrence of mitral regurgitation was observed in 10 (4.6 %) cases.

Results. According to the clinical and histological causes of mitral regurgitation, we systematized and conducted a comparative analysis between groups of patients with primary (n = 174) and secondary (n = 44) mitral regurgitation. The group with primary mitral regurgitation (n = 174) in the early postoperative period was characterized by averagely shorter duration of the total time of artificial ventilation compared with the secondary genesis of mitral regurgitation. Thus, in the group of patients with secondary mitral regurgitation significantly (P = 0.003) more often there were signs of acute cardiac insufficiency. Hospital mortality for the whole group of patients was 5 (2.3 %) cases. In the group with secondary mitral regurgitation, hospital mortality was significantly higher and amounted to – 6.8 % (3 cases in 44 patients), against 1.2 % (2 cases in 174 patients) in primary mitral regurgitation.

Conclusions. Primary mitral regurgitation occurs due to a violation of the anatomy of the valvular apparatus, accompanied by increased mobility of the valves (prolapse) and regurgitation. Hospital mortality in primary mitral regurgitation was 1.2 %. Survival after 6 months and by the end of 1 and 5 years was 98.8 %, 98.2 % and 97.0 %, respectively. Secondary mitral regurgitation is caused by the initial dilatation of the left ventricle with preserved anatomy of the valvular apparatus. Hospital mortality was 6.8 %. Survival rate after 6 months, by the end of 1, 3 and 5 years, was 90.9 %, 86.3 %, 77.9 % and 74.0 % respectively.

References

Tsang, W. (2019). Recent advances in understanding and managing mitral valve disease [version 1; peer review: 2 approved]. F1000Research 2019, 8(F1000 Faculty Rev), Article 1686. https://doi.org/10.12688/f1000research.16066.1

Wu, S., Chai, A., Arimie, S., Mehra, A., Clavijo, L., Matthews, R. V., & Shavelle, D. M. (2018). Incidence and treatment of severe primary mitral regurgitation in contemporary clinical practice. Cardiovascular Revascularization Medicine, 19(8), 960-963. https://doi.org/10.1016/j.carrev.2018.07.021

Falk, V., Baumgartner, H., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Muñoz, D. R., Rosenhek, R., Sjögren, J., Tornos Mas, P., Vahanian, A., Walther, T., Wendler, O., Windecker, S., Zamorano, J. L., & ESC Scientific Document Group. (2017). 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Journal of Cardio-Thoracic Surgery, 52(4), 616-664. https://doi.org/10.1093/ejcts/ezx324

Coutinho, G. F., & Antunes, M. J. (2017). Mitral valve repair for degenerative mitral valve disease: surgical approach, patient selection and long-term outcomes. Heart, 103(21), 1663-1669. https://doi.org/10.1136/heartjnl-2016-311031

Cohn, L. H., Tchantchaleishvili, V., & Rajab, T. K. (2015). Evolution of the concept and practice of mitral valve repair. Annals of Cardiothoracic Surgery, 4(4), 315-321. https://doi.org/10.3978/j.issn.2225-319X.2015.04.09

De Bonis, M., Alfieri, O., Dalrymple-Hay, M., Del Forno, B., Dulguerov, F., & Dreyfus, G. (2017). Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art. Progress in Cardiovascular Diseases, 60(3), 386-393. https://doi.org/10.1016/j.pcad.2017.10.006

Fan, H. G., Marcacci, C., Dulguerov, F., & Dreyfus, G. D. (2018). Degenerative Mitral Valve Repair: From Etiology, Pathology, Surgical Strategy to Durability. Chinese Medical Journal, 131(20), 2486-2488. https://doi.org/10.4103/0366-6999.243562

Gammie, J. S., Chikwe, J., Badhwar, V., Thibault, D. P., Vemulapalli, S., Thourani, V. H., Gillinov, M., Adams, D. H., Rankin, J. S., Ghoreishi, M., Wang, A., Ailawadi, G., Jacobs, J. P., Suri, R. M., Bolling, S. F., Foster, N. W., & Quinn, R. W. (2018). Isolated Mitral Valve Surgery: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis. The Annals of Thoracic Surgery, 106(3), 716-727. https://doi.org/10.1016/j.athoracsur.2018.03.086

Rostagno, C., Carone, E., & Stefàno, P. L. (2017). Role of mitral valve repair in active infective endocarditis: long term results. Journal of Cardiothoracic Surgery, 12(1), Article 29. https://doi.org/10.1186/s13019-017-0604-6

Mihos, C. G., Xydas, S., Yucel, E., Capoulade, R., Williams, R. F., Mawad, M., Garcia, G., & Santana, O. (2017). Mitral valve repair and subvalvular intervention for secondary mitral regurgitation: a systematic review and meta-analysis of randomized controlled and propensity matched studies. Journal of Thoracic Disease, 9(Suppl. 7), S582-S594. https://doi.org/10.21037/jtd.2017.05.56

Mihos, C. G., Yucel, E., & Santana, O. (2017). The role of papillary muscle approximation in mitral valve repair for the treatment of secondary mitral regurgitation. European Journal of Cardio-Thoracic Surgery, 51(6), 1023-1030. https://doi.org/10.1093/ejcts/ezw384

Schubert, S. A., Mehaffey, J. H., Charles, E. J., & Kron, I. L. (2017). Mitral Valve Repair: The French Correction Versus the American Correction. The Surgical Clinics of North America, 97(4), 867-888. https://doi.org/10.1016/j.suc.2017.03.009

Mantovani, F., Bursi, F., Di Giannuario, G., & Barbieri, A. (2019). Echocardiographic prediction of surgical reparability in degenerative mitral regurgitation due to leaflet prolapse: a review. Expert Review of Cardiovascular Therapy, 17(9), 653-662. https://doi.org/10.1080/14779072.2019.1664289

Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., Rosenhek, R., Sjögren, J., Tornos Mas, P., Vahanian, A., Walther, T., Wendler, O., Windecker, S., Zamorano, J. L., & ESC Scientific Document Group. (2017). 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal, 38(36), 2739-2791. https://doi.org/10.1093/eurheartj/ehx391

How to Cite

1.
Luchynets OF, Lazoryshynets VV, Krykunov OA. Clinical manifestations and results of reconstructive surgeries in patients with primary and secondary mitral insufficiency. Zaporozhye medical journal [Internet]. 2020Dec.9 [cited 2024Apr.25];22(6). Available from: http://zmj.zsmu.edu.ua/article/view/218401

Issue

Section

Original research